QSAR studies on peptide α-ketoamides and α-ketohydroxamate derivatives as calpain I inhibitors

References

• DE Goll, VF Thompson, H Li, W Wei, and J Cong. (2003). The calpain system. Physiol Rev 83:731–801.
   PubMed Web of Science ®Google Scholar
• TC Saido, H Sorimachi, and K Suzuki. (1994). Calpain: New perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8:814–822.
   PubMed Web of Science ®Google Scholar
• K Suzuki, and H Sorimachi. (1998). A novel aspect of calpain activation. FEBS Lett 433:1–4.
   PubMed Web of Science ®Google Scholar
• M Zatz, and A Starling. (2005). Calpains and disease. N Engl J Med 352:2413–2423.
   PubMed Web of Science ®Google Scholar
• Y Huang, and KK Wang. (2001). The calpain family and human disease. TRENDS Mol Med 7:355–362.
   PubMed Web of Science ®Google Scholar
• C Crawford, RW Mason, P Wikstrom, and E Shaw. (1988). The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem J 253:751–758.
   PubMed Web of Science ®Google Scholar
• EB McGowan, E Becker, and TC Detwiler. (1989). Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. Biochem Biophys Res Commun 158:432–435.
   PubMed Web of Science ®Google Scholar
• Z Huang, EB McGowan, and TC Detwiler. (1992). Ester and amide derivatives of E64c as inhibitors of platelet calpains. J Med Chem 35:2048–2054.
   PubMed Web of Science ®Google Scholar
• IO Donkor. (2000). A survey of calpain inhibitors. Curr Med Chem 7:1171–1188.
   PubMed Web of Science ®Google Scholar
• H Angliker, J Anagli, and E Shaw. (1992). Inactivation of calpain by peptidyl fluoromethyl ketones. J Med Chem 35:216–220.
   PubMed Web of Science ®Google Scholar
• S Chatterjee, MA Ator, D Bozyczko-Coyne, K Josef, G Wells, R Tripathy, M Iqbal, R Bihovsky, SE Senadhi, S Mallya, TM O'Kane, BA McKenna, R Siman, and JP Mallamo. (1997). Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I. J Med Chem 40:3820–3828.
   PubMed Web of Science ®Google Scholar
• AJ Barrett, AA Kembhavi, MA Brown, H Kirschke, CG Knight, M Tamai, and K Hanada. (1982). L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201:189–198.
   PubMed Web of Science ®Google Scholar
• T Sasaki, M Kishi, M Saito, T Tanaka, N Higuchi, E Kominami, N Katunuma, and T Murachi. (1990). Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J Enz Inhib 3:195–201.
   Google Scholar
• M Iqbal, PA Messina, B Freed, M Das, S Chatterjee, R Tripathy, M Tao, KA Josef, B Dembofsky, D Dunn, E Griffith, R Siman, SE Senadhi, W Biazzo, D Bozyczko-Coyne, SL Meyer, MA Ator, and R Bihovsky. (1997). Subsite requirements for peptide aldehyde inhibitors of human calpain I. Bioorg Med Chem Lett 7:539–544.
   Web of Science ®Google Scholar
• MR Angelastro, S Mehdi, JP Burkhart, NP Peet, and P Bey. (1990). Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. J Med Chem 33:11–13.
   PubMed Web of Science ®Google Scholar
• Z Li, GS Patil, ZE Golubski, H Hori, K Tehrani, JE Foreman, DD Eveleth, RT Bartus, and JC Powers. (1993). Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases. J Med Chem 36:3472–3480.
   PubMed Web of Science ®Google Scholar
• C Lescop, H Herzner, H Siendt, R Bolliger, M Henneböhle, P Weyermann, A Briguet, I Courdier-Fruh, M Erb, M Foster, T Meier, JP Magyar, and A von Sprecher. (2005). Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy. Bioorg Med Chem Lett 15:5176–5181.
   PubMed Web of Science ®Google Scholar
• M Lee Sanders, and IO Donkor. (2006). A novel series of urea-based peptidomimetic calpain inhibitors. Bioorg Med Chem Lett 16:1965–1968.
   PubMed Web of Science ®Google Scholar
• Y Shirasaki, H Miyashita, M Yamaguchi, J Inoue, and M Nakamura. (2005). Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site. Bioorg Med Chem 13:4473–4484.
   PubMed Web of Science ®Google Scholar
• Y Shirasaki, H Miyashita, and M Yamaguchi. (2006). Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. Bioorg Med Chem 14:5691–5698.
   PubMed Web of Science ®Google Scholar
• KA Josef, FW Kauer, and R Bihovsky. (2001). Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I. Bioorg Med Chem Lett 11:2615–2617.
   PubMed Web of Science ®Google Scholar
• GJ Wells, and R Bihovsky. (1998). Calpain inhibitors as potential treatment for stroke and other neurodegenerative diseases: Recent trends and developments. Exp Opin Ther Patents 8:1707–1727.
   Web of Science ®Google Scholar
• M Nakamura, and J Inoue. (2002). Exploration of peptidyl hydrazones as water-soluble calpain inhibitors. Bioorg Med Chem Lett 12:1603–1606.
   PubMed Web of Science ®Google Scholar
• A Golbraikh, and A Tropsha. (2002). Beware of q2. J Mol Graph Model 20:269–276.
   PubMed Web of Science ®Google Scholar
• A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, J Markopoulos, and O Igglessi-Markopoulou. (2006). Bioorg Med Chem 14:6686–6694.
   PubMed Web of Science ®Google Scholar
• Kim Dooil, Hong Suk-In, and Lee Dae-Sil. (2006). The quantitative structure-mutagenicity relationship of polycylic aromatic hydrocarbon metabolites. Int J Mol Sci 7:556–570.
   Web of Science ®Google Scholar
• N Cohen, and SW Benson. (1993). Estimation of heats of formation of organic compounds by additivity methods. Chem Rev 93:2419–2438.
   Web of Science ®Google Scholar
• BB Lohray, G Neha, KS Brijesh, and BL Vidya. (2006). 3D QSARs studies of N-4-arylacryloylpiperazin-1-yl-phenyloxazolidinones: A novel class of antibacterial agents. Bioorg Med Chem Lett 16:3817–3823.
   PubMed Web of Science ®Google Scholar
• L Venkataraman, YS Park, AC Whalley, C Nuckolls, MS Hybertsen, and ML Steigerwald. (2007). Electronics and chemistry: Varying single-molecule junction conductance using chemical substituents. Nano Lett 7:502–506.
   PubMed Web of Science ®Google Scholar
• R Mannhold, and A Petrauskas. (2003). QSAR Comb Sci 22:466–475.
   Google Scholar
• WPA Walters, and MA Murcko. (1999). Curr Opin Chem Biol 3:384–387.
   PubMed Web of Science ®Google Scholar